Market research
CWAB.F Chemesis International Inc
F EUR Healthcare
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 7M
- P/E ratio
- Not available
- Analyst target
- Not available
- Dividend yield
- 0.0%
- Beta
- 1.52
Community
Investor discussion
1 comment
Sign in to join the CWAB.F discussion.
5 years, 4 months ago
Chemesis International Inc is currently in a long term downtrend where the price is trading 24.5% below its 200 day moving average.
From a valuation standpoint, the stock is 99.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.5.
Chemesis International Inc's total revenue sank by 100.0% to $0 since the same quarter in the previous year.
Its net income has increased by 38.0% to $-10M since the same quarter in the previous year.
Finally, its free cash flow grew by 170.4% to $3M since the same quarter in the previous year.
Based on the above factors, Chemesis International Inc gets an overall score of 3/5.